CA2385529A1 - Formulations posologiques stables contenant de l'atorvastatin calcium - Google Patents

Formulations posologiques stables contenant de l'atorvastatin calcium Download PDF

Info

Publication number
CA2385529A1
CA2385529A1 CA 2385529 CA2385529A CA2385529A1 CA 2385529 A1 CA2385529 A1 CA 2385529A1 CA 2385529 CA2385529 CA 2385529 CA 2385529 A CA2385529 A CA 2385529A CA 2385529 A1 CA2385529 A1 CA 2385529A1
Authority
CA
Canada
Prior art keywords
sodium
composition
atorvastatin calcium
tribasic
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2385529
Other languages
English (en)
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2385529 priority Critical patent/CA2385529A1/fr
Priority to AU2003229181A priority patent/AU2003229181A1/en
Priority to PCT/CA2003/000710 priority patent/WO2003097039A1/fr
Publication of CA2385529A1 publication Critical patent/CA2385529A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2385529 2002-05-21 2002-05-21 Formulations posologiques stables contenant de l'atorvastatin calcium Abandoned CA2385529A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA 2385529 CA2385529A1 (fr) 2002-05-21 2002-05-21 Formulations posologiques stables contenant de l'atorvastatin calcium
AU2003229181A AU2003229181A1 (en) 2002-05-21 2003-05-15 Stable dosage forms comprising atorvastatin calcium
PCT/CA2003/000710 WO2003097039A1 (fr) 2002-05-21 2003-05-15 Formes de dosage stables contenant du calcium d'atorvastatine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2385529 CA2385529A1 (fr) 2002-05-21 2002-05-21 Formulations posologiques stables contenant de l'atorvastatin calcium

Publications (1)

Publication Number Publication Date
CA2385529A1 true CA2385529A1 (fr) 2003-11-21

Family

ID=29425923

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2385529 Abandoned CA2385529A1 (fr) 2002-05-21 2002-05-21 Formulations posologiques stables contenant de l'atorvastatin calcium

Country Status (3)

Country Link
AU (1) AU2003229181A1 (fr)
CA (1) CA2385529A1 (fr)
WO (1) WO2003097039A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2465693A1 (fr) * 2003-06-12 2004-12-12 Warner-Lambert Company Llc Compositions pharmaceutiques d'atorvastatine
EP1819319A1 (fr) * 2004-12-02 2007-08-22 Warner-Lambert Company LLC Compositions pharmaceutiques d'atorvastatine amorphe et leur procede de preparation
EP1810667A1 (fr) * 2006-01-20 2007-07-25 KRKA, tovarna zdravil, d.d., Novo mesto Composition pharmaceutique contenant de l'atorvastatin amorphé
RU2014124118A (ru) 2011-11-15 2015-12-27 Др. Редди'С Лабораторис Лтд. Фармацевтические препараты, включающие аторвастатин и глимепирид
WO2014008374A2 (fr) * 2012-07-06 2014-01-09 Thetis Pharmaceuticals Llc Thérapies combinées comprenant des sels de metformine et des agents antihyperglycémie ou des agents antihyperlipidémie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
DK0680320T3 (da) * 1993-01-19 1999-10-25 Warner Lambert Co Stabilt oralt CI-981-præparat og fremgangsmåde til fremstilling deraf
SI20109A (sl) * 1998-12-16 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Stabilna farmacevtska formulacija
WO2001076566A1 (fr) * 2000-04-10 2001-10-18 Teva Pharmaceutical Industries Ltd. Compositions pharmaceutiques stables contenant des acides 7-substitues-3,5-dihydroxyheptanoiques ou acides 7-substitues-3,5-dihydroxyheptenoiques
WO2001093860A1 (fr) * 2000-06-09 2001-12-13 Lek Pharmaceuticals D.D. Composition stabilisee pharmaceutiquement efficace et preparation pharmaceutique comprenant cette composition
SI20814A (sl) * 2001-01-23 2002-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Priprava amorfnega atorvastatina
SI20848A (sl) * 2001-03-14 2002-10-31 Lek, Tovarna Farmacevtskih In Kemijskih Izdelkov, D.D. Farmacevtska formulacija, ki vsebuje atorvastatin kalcij

Also Published As

Publication number Publication date
WO2003097039A1 (fr) 2003-11-27
AU2003229181A1 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
RU2206324C1 (ru) Фармацевтические композиции, содержащие ингибитор hmg редуктазы
JP4948392B2 (ja) 固形薬学的組成物を調製するためのプロセス
SK282991B6 (sk) Stabilizovaná farmaceutická kompozícia na báze kyseliny (E)- 3,5-dihydroxy-7-[4'-4''-fluórfenyl-2'-cyklopropylchinolin-3'yl]- 6-hepténovej
RU2001115716A (ru) Твердый фармацевтический препарат, содержащий ингибитор hmg-coa-редуктазы
SK8092001A3 (en) Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
US20090292016A1 (en) Stable Pharmaceutical Compositions Containing Pravastatin
AU2008277444B2 (en) Stable pharmaceutical compositions comprising one or more HMG-CoA reductase inhibitors
EA015682B1 (ru) Фармацевтическая композиция
WO2007100822A2 (fr) Compositions pharmaceutiques de fluvastatine sodique
CA2612769A1 (fr) Composition pharmaceutique amelioree contenant un inhibiteur de la hmg-coa reductase et procede d'elaboration correspondant
US20080038332A1 (en) Stable pharmaceutical formulation comprising atorvastatin calcium
CA2385529A1 (fr) Formulations posologiques stables contenant de l'atorvastatin calcium
EP0468929A2 (fr) Compositions pharmaceutiques stabilisées
AU2007355452B2 (en) Improved pharmaceutical formulation containing an HMG-CoA reductase inhibitor and method for the preparation thereof
US20080182887A1 (en) Stable Oral Pharmaceutical Composition
KR101098597B1 (ko) 에이취엠지-코에이 환원효소 억제제를 함유하는 안정한 약제학적 조성물
JP2004250382A (ja) プラバスタチンナトリウムを含有する固形製剤の包装体
WO2008117154A2 (fr) Compositions pharmaceutiques stables d'inhibiteur de hmg-coa réductase et leur procédé de préparation
RO129060B1 (ro) Compoziţie farmaceutică stabilă cu rosuvastatină calcică amorfă
US20190070167A1 (en) Pitavastatin containing preparation and method for producing same
WO2009091346A2 (fr) Formulation pharmaceutique stable et procédés de préparation
NZ582667A (en) Combination of an HMG-CoA reductase inhibitor and a colloidal clay, and method for the preparation thereof
AU2002314915A1 (en) Stable pharmaceutical compositions containing pravastatin

Legal Events

Date Code Title Description
FZDE Dead